You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model

 

Online download statistics by month:

Online download statistics by month: August 2020 to July 2022

AbstractFullPdf
Aug 202016516554
Sep 2020348348128
Oct 202019419460
Nov 202018318268
Dec 202017217241
Jan 202120320381
Feb 202116716753
Mar 202115115154
Apr 202113113137
May 202111111129
Jun 2021969644
Jul 2021838343
Aug 2021656530
Sep 2021959548
Oct 202114214270
Nov 2021858553
Dec 2021626329
Jan 2022646618
Feb 202211511925
Mar 2022768336
Apr 2022707342
May 2022809048
Jun 2022869229
Jul 2022737636
Total301730521156